Evaluation of tofacitinib in cutaneous sarcoidosis [scRNA-seq]
Ontology highlight
ABSTRACT: Sarcoidosis is a multisystem inflammatory disease and no molecularly targeted therapies exist. Here we evaluate the efficacy of tofacitinib (a JAK1/3 inhibitor) in an open-label trial of 10 patients with sarcoidosis and correlate clinical improvement with molecular parameters in blood and skin.
ORGANISM(S): Homo sapiens
PROVIDER: GSE169147 | GEO | 2022/03/30
REPOSITORIES: GEO
ACCESS DATA
